Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa Treated With Ceftolozane/Tazobactam.

Rodríguez-Núñez O, Periañez-Parraga L, Oliver A, Munita JM, Boté A, Gasch O, Nuvials X, Dinh A, Shaw R, Lomas JM, Torres V, Castón J, Araos R, Abbo LM, Rakita R, Pérez F, Aitken SL, Arias CA, Martín-Pena ML, Colomar A, Núñez MB, Mensa J, Martínez JA, Soriano A.

Open Forum Infect Dis. 2019 Sep 28;6(10):ofz416. doi: 10.1093/ofid/ofz416. eCollection 2019 Oct.

2.

A One Health - One World initiative to control antibiotic resistance: A Chile - Sweden collaboration.

Cabrera-Pardo JR, Lood R, Udekwu K, Gonzalez-Rocha G, Munita JM, Järhult JD, Opazo-Capurro A.

One Health. 2019 Aug 14;8:100100. doi: 10.1016/j.onehlt.2019.100100. eCollection 2019 Dec.

3.

Corrigendum to "In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways".

Skoglund E, Abodakpi H, Rios R, Diaz L, De La Cadena E, Dinh AQ, Ardila J, Miller WR, Munita JM, Arias CA, Tam VH, Tran TT.

Case Rep Infect Dis. 2019 Sep 2;2019:8314349. doi: 10.1155/2019/8314349. eCollection 2019.

4.

Managing All the Genotypic Knowledge: Approach to a Septic Patient Colonized by Different Enterobacteriales with Unique Carbapenemases.

Park SC, Wailan AM, Barry KE, Vegesana K, Carroll J, Mathers AJ, Miller WR, Munita JM.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00029-19. doi: 10.1128/AAC.00029-19. Print 2019 Aug.

5.

A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage.

Khan A, Rivas LM, Spencer M, Martinez R, Lam M, Rojas P, Porte L, Silva F, Braun S, Valdivieso F, Mv Lhauser M, Lafourcade M, Miller WR, García P, Arias CA, Munita JM.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00798-19. doi: 10.1128/JCM.00798-19. Print 2019 Sep.

6.

Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections.

Contreras GA, Munita JM, Arias CA.

Curr Infect Dis Rep. 2019 May 22;21(7):22. doi: 10.1007/s11908-019-0680-y. Review.

PMID:
31119397
7.

Laboratory exposure to Coccidioides: lessons learnt in a non-endemic country.

Porte L, Valdivieso F, Wilmes D, Gaete P, Díaz MC, Thompson L, Munita JM, Alliende R, Varela C, Rickerts V, Weitzel T.

J Hosp Infect. 2019 Aug;102(4):461-464. doi: 10.1016/j.jhin.2019.03.006. Epub 2019 Mar 16.

PMID:
30885815
8.

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways.

Skoglund E, Abodakpi H, Rios R, Diaz L, De La Cadena E, Dinh AQ, Ardila J, Miller WR, Munita JM, Arias CA, Tam VH, Tran TT.

Case Rep Infect Dis. 2018 Dec 23;2018:9095203. doi: 10.1155/2018/9095203. eCollection 2018. Erratum in: Case Rep Infect Dis. 2019 Sep 2;2019:8314349.

9.

Imported scrub typhus: first case in South America and review of the literature.

Weitzel T, Aylwin M, Martínez-Valdebenito C, Jiang J, Munita JM, Thompson L, Abarca K, Richards AL.

Trop Dis Travel Med Vaccines. 2018 Aug 16;4:10. doi: 10.1186/s40794-018-0070-8. eCollection 2018.

10.

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Miller WR, Seas C, Carvajal LP, Diaz L, Echeverri AM, Ferro C, Rios R, Porras P, Luna C, Gotuzzo E, Munita JM, Nannini E, Carcamo C, Reyes J, Arias CA.

Open Forum Infect Dis. 2018 May 23;5(6):ofy123. doi: 10.1093/ofid/ofy123. eCollection 2018 Jun 1.

11.

Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.

Kebriaei R, Rice SA, Singh KV, Stamper KC, Dinh AQ, Rios R, Diaz L, Murray BE, Munita JM, Tran TT, Arias CA, Rybak MJ.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00315-18. doi: 10.1128/AAC.00315-18. Print 2018 Aug.

12.

Erratum for Arias et al., "A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries".

Arias CA, Reyes J, Carvajal LP, Rincon S, Diaz L, Panesso D, Ibarra G, Rios R, Munita JM, Salles MJ, Alvarez-Moreno C, Labarca J, Garcia C, Luna CM, Mejia-Villatoro C, Zurita J, Guzman-Blanco M, Rodriguez-Noriega E, Narechania A, Rojas LJ, Planet PJ, Weinstock GM, Gotuzzo E, Seas C.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e00095-18. doi: 10.1128/AAC.00095-18. Print 2018 Mar. No abstract available.

13.

A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries.

Arias CA, Reyes J, Carvajal LP, Rincon S, Diaz L, Panesso D, Ibarra G, Rios R, Munita JM, Salles MJ, Alvarez-Moreno C, Labarca J, Garcia C, Luna CM, Mejia-Villatoro C, Zurita J, Guzman-Blanco M, Rodriguez-Noriega E, Narechania A, Rojas LJ, Planet PJ, Weinstock GM, Gotuzzo E, Seas C.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00816-17. doi: 10.1128/AAC.00816-17. Print 2017 Oct. Erratum in: Antimicrob Agents Chemother. 2018 Feb 23;62(3):.

14.

Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens.

Shelburne SA, Kim J, Munita JM, Sahasrabhojane P, Shields RK, Press EG, Li X, Arias CA, Cantarel B, Jiang Y, Kim MS, Aitken SL, Greenberg DE.

Clin Infect Dis. 2017 Sep 1;65(5):738-745. doi: 10.1093/cid/cix417.

15.

Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.

Doernberg SB, Lodise TP, Thaden JT, Munita JM, Cosgrove SE, Arias CA, Boucher HW, Corey GR, Lowy FD, Murray B, Miller LG, Holland TL; Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG).

Clin Infect Dis. 2017 Mar 15;64(suppl_1):S24-S29. doi: 10.1093/cid/ciw828. Review.

16.

Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.

Munita JM, Aitken SL, Miller WR, Perez F, Rosa R, Shimose LA, Lichtenberger PN, Abbo LM, Jain R, Nigo M, Wanger A, Araos R, Tran TT, Adachi J, Rakita R, Shelburne S, Bonomo RA, Arias CA.

Clin Infect Dis. 2017 Jul 1;65(1):158-161. doi: 10.1093/cid/cix014.

17.

Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.

Nigo M, Diaz L, Carvajal LP, Tran TT, Rios R, Panesso D, Garavito JD, Miller WR, Wanger A, Weinstock G, Munita JM, Arias CA, Chambers HF.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01235-16. doi: 10.1128/AAC.01235-16. Print 2017 Mar.

18.

The Growing Threat of Antimicrobial Resistance.

Munita JM, Shelburne S, Greenberg DE, Arias CA.

Tex Med. 2017 Feb 1;113(2):48-52.

PMID:
28207079
19.

Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.

DiPippo AJ, Tverdek FP, Tarrand JJ, Munita JM, Tran TT, Arias CA, Shelburne SA, Aitken SL.

J Infect. 2017 Mar;74(3):243-247. doi: 10.1016/j.jinf.2016.11.004. Epub 2016 Nov 11.

20.

Mechanisms of Antibiotic Resistance.

Munita JM, Arias CA.

Microbiol Spectr. 2016 Apr;4(2). doi: 10.1128/microbiolspec.VMBF-0016-2015. Review.

21.

Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?

Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi J, Munita JM, Hasbun R, Arias CA.

Clin Infect Dis. 2016 Jun 15;62(12):1514-1520. doi: 10.1093/cid/ciw173. Epub 2016 Apr 3.

22.

Fungal empyema thoracis in cancer patients.

Nigo M, Vial MR, Munita JM, Jiang Y, Tarrand J, Jimenez CA, Kontoyiannis DP.

J Infect. 2016 May;72(5):615-21. doi: 10.1016/j.jinf.2016.02.014. Epub 2016 Mar 2.

PMID:
26945845
23.

Mechanisms of drug resistance: daptomycin resistance.

Tran TT, Munita JM, Arias CA.

Ann N Y Acad Sci. 2015 Sep;1354:32-53. doi: 10.1111/nyas.12948. Epub 2015 Oct 23. Review.

24.

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.

Panesso D, Planet PJ, Diaz L, Hugonnet JE, Tran TT, Narechania A, Munita JM, Rincon S, Carvajal LP, Reyes J, Londoño A, Smith H, Sebra R, Deikus G, Weinstock GM, Murray BE, Rossi F, Arthur M, Arias CA.

Emerg Infect Dis. 2015 Oct;21(10):1844-8. doi: 10.3201/eid2110.141914.

25.

Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background.

Panesso D, Reyes J, Gaston EP, Deal M, Londoño A, Nigo M, Munita JM, Miller WR, Shamoo Y, Tran TT, Arias CA.

Antimicrob Agents Chemother. 2015 Dec;59(12):7327-34. doi: 10.1128/AAC.01073-15. Epub 2015 Sep 14.

26.

Evolving resistance among Gram-positive pathogens.

Munita JM, Bayer AS, Arias CA.

Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S48-57. doi: 10.1093/cid/civ523. Review.

27.

A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.

Reyes J, Panesso D, Tran TT, Mishra NN, Cruz MR, Munita JM, Singh KV, Yeaman MR, Murray BE, Shamoo Y, Garsin D, Bayer AS, Arias CA.

J Infect Dis. 2015 Apr 15;211(8):1317-25. doi: 10.1093/infdis/jiu602. Epub 2014 Oct 31.

28.

Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci.

Munita JM, Murray BE, Arias CA.

Int J Antimicrob Agents. 2014 Nov;44(5):387-95. doi: 10.1016/j.ijantimicag.2014.08.002. Epub 2014 Sep 2. Review.

29.

Mechanisms of antibiotic resistance in enterococci.

Miller WR, Munita JM, Arias CA.

Expert Rev Anti Infect Ther. 2014 Oct;12(10):1221-36. doi: 10.1586/14787210.2014.956092. Review.

30.

What's New in the Treatment of Enterococcal Endocarditis?

Nigo M, Munita JM, Arias CA, Murray BE.

Curr Infect Dis Rep. 2014 Oct;16(10):431. doi: 10.1007/s11908-014-0431-z.

31.

Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.

Munita JM, Mishra NN, Alvarez D, Tran TT, Diaz L, Panesso D, Reyes J, Murray BE, Adachi JA, Bayer AS, Arias CA.

Clin Infect Dis. 2014 Nov 1;59(9):1277-80. doi: 10.1093/cid/ciu642. Epub 2014 Aug 8.

32.

[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].

Rincón S, Panesso D, Díaz L, Carvajal LP, Reyes J, Munita JM, Arias CA.

Biomedica. 2014 Apr;34 Suppl 1:191-208. doi: 10.1590/S0120-41572014000500022. Review. Spanish.

33.

Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.

Diaz L, Tran TT, Munita JM, Miller WR, Rincon S, Carvajal LP, Wollam A, Reyes J, Panesso D, Rojas NL, Shamoo Y, Murray BE, Weinstock GM, Arias CA.

Antimicrob Agents Chemother. 2014 Aug;58(8):4527-34. doi: 10.1128/AAC.02686-14. Epub 2014 May 27.

34.

Transferable vancomycin resistance in a community-associated MRSA lineage.

Rossi F, Diaz L, Wollam A, Panesso D, Zhou Y, Rincon S, Narechania A, Xing G, Di Gioia TS, Doi A, Tran TT, Reyes J, Munita JM, Carvajal LP, Hernandez-Roldan A, Brandão D, van der Heijden IM, Murray BE, Planet PJ, Weinstock GM, Arias CA.

N Engl J Med. 2014 Apr 17;370(16):1524-31. doi: 10.1056/NEJMoa1303359. Erratum in: N Engl J Med. 2014 Jun 5;370(23):2253.

35.

Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids.

Tran TT, Panesso D, Mishra NN, Mileykovskaya E, Guan Z, Munita JM, Reyes J, Diaz L, Weinstock GM, Murray BE, Shamoo Y, Dowhan W, Bayer AS, Arias CA.

mBio. 2013 Jul 23;4(4). pii: e00281-13. doi: 10.1128/mBio.00281-13.

36.

Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus.

Diaz L, Kontoyiannis DP, Panesso D, Albert ND, Singh KV, Tran TT, Munita JM, Murray BE, Arias CA.

J Infect Dis. 2013 Jul;208(1):83-91. doi: 10.1093/infdis/jit138. Epub 2013 Apr 1.

37.

A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis.

Munita JM, Tran TT, Diaz L, Panesso D, Reyes J, Murray BE, Arias CA.

Antimicrob Agents Chemother. 2013 Jun;57(6):2831-3. doi: 10.1128/AAC.00021-13. Epub 2013 Mar 18.

38.

Editorial Commentary: Enterococcus faecalis infective endocarditis: is it time to abandon aminoglycosides?

Munita JM, Arias CA, Murray BE.

Clin Infect Dis. 2013 May;56(9):1269-72. doi: 10.1093/cid/cit050. Epub 2013 Feb 7. No abstract available.

PMID:
23392395
39.

Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy.

Tran TT, Panesso D, Gao H, Roh JH, Munita JM, Reyes J, Diaz L, Lobos EA, Shamoo Y, Mishra NN, Bayer AS, Murray BE, Weinstock GM, Arias CA.

Antimicrob Agents Chemother. 2013 Jan;57(1):261-8. doi: 10.1128/AAC.01454-12. Epub 2012 Oct 31.

40.

Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.

Munita JM, Panesso D, Diaz L, Tran TT, Reyes J, Wanger A, Murray BE, Arias CA.

Antimicrob Agents Chemother. 2012 Aug;56(8):4354-9. doi: 10.1128/AAC.00509-12. Epub 2012 Jun 4.

41.

Enterococcal endocarditis: can we win the war?

Munita JM, Arias CA, Murray BE.

Curr Infect Dis Rep. 2012 Aug;14(4):339-49. doi: 10.1007/s11908-012-0270-8.

42.

Pandemic influenza A (H1N1) 2009 with neurological manifestations, a case series.

Noriega LM, Verdugo RJ, Araos R, Munita JM, Díaz V, Marcotti A, Perez J, Gonzalez P, Thompson L, Canals M, Hoppe A, Mounts AW, Vial PA.

Influenza Other Respir Viruses. 2010 May 1;4(3):117-20. doi: 10.1111/j.1750-2659.2010.00131.x.

43.

[Community acquired infections with methicillin resistant strains of Staphylococcus aureus: report of five cases].

Noriega LM, González P, Hormazábal JC, Pinto C, Canals M, Munita JM, Thompson L, Marcotti A, Pérez J, Ibáñez D, Araya P, Canals C, Vial P.

Rev Med Chil. 2008 Jul;136(7):885-91. doi: /S0034-98872008000700010. Epub 2008 Sep 4. Spanish.

Supplemental Content

Loading ...
Support Center